ArticlePharmaceuticals (Basel, Switzerland)2025

Neurological Adverse Events Associated with the Use of Janus Kinase Inhibitors: A Pharmacovigilance Study Based on Vigibase.

Sunny Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.